Drug Profile
SUPG 032
Alternative Names: LEX 032Latest Information Update: 16 Nov 2006
Price :
$50
*
At a glance
- Originator SuperGen
- Class Anti-inflammatories; Anti-ischaemics
- Mechanism of Action Cathepsin G inhibitors; Leucocyte elastase inhibitors; Serine endopeptidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation; Reperfusion injury; Stroke